Magnetic nanoparticle (mNP) hyperthermia is a promising adjuvant cancer therapy. mNP's are delivered intravenously or directly into a tumor, and excited by applying an alternating magnetic field (AMF). The mNP's are, in many cases, sequestered by cells and packed into endosomes. The proximity of the mNP's has a strong influence on their ability to heat due to inter-particle magnetic interaction effects. This is an important point to take into account when modeling the mNP's. Generally, more mNP heating can be achieved using higher magnetic field strengths. The factor which limits the maximum field strength applied to clinically relevant volumes of tissue is the heating caused by eddy currents, which are induced in the noncancerous tissue. A coupled electromagnetic and thermal model has been developed to predict dynamic thermal distributions during AMF treatment. The EM model is based on the method of auxiliary sources and the thermal modeling is based on the Pennes bioheat equation. The results of our phantom study are used to validate the model which takes into account nanoparticle heating, interaction effects, particle spatial distribution, particle size distribution, EM field distribution, and eddy current generation in a controlled environment. Preliminary in vivo data for model validation are also presented. Once fully developed and validated, the model will have applications in experimental design, AMF coil design, and treatment planning.
INTRODUCTION
Surgery, radiation and chemotherapy are the current standards of care for the treatment of cancer. Clinical hyperthermia has not yet achieved this status but has proven effective, especially in an adjuvant setting [1] [2] [3] [4] [5] [6] . One of the limitations inherent to hyperthermia is that cancerous and noncancerous tissues tend to have similar sensitivities to heat 7 . The lack of an innate differential sensitivity precludes the use of hyperthermia as a global therapy, effectively necessitating high specificity in the application of the heat source. Nanoparticle hyperthermia addresses this need by allowing for an amorphous spatial distribution of small heat sources which can in many cases be targeted to cancer cells [8] [9] [10] .
There are some fundamental similarities between the characteristics of an effective nanoparticle hyperthermia and radiation therapy treatment, driven by the common need for a highly localized treatment. Both must be targeted to the cancerous tissue, are limited by potential normal tissue cytotoxicity in the treatment region, and in most cases require effective and informative imaging of the patient and patient specific treatment planning. There are many treatment planning software packages available for radiation treatment planning 11 . They commonly include clinician guided or partially automated image segmentation of regions with varying dose limitations, suggested number of beams, beam angles, and beam specific multi-leaf collimator settings. This is all done in an effort to maximize dose to the target while minimizing the dose to the surrounding normal tissue, and has been shown to increase treatment efficacy [12] [13] [14] . To this date there does not exist a clinical treatment planning model for magnetic nanoparticle hyperthermia which is robust, validated, and commercially available. The work presented here documents our group's efforts to develop such a model, focusing on experimental validation.
METHODS

Computational modeling
The electromagnetic model is based on the Method of Auxiliary Sources (MAS), a robust, accurate numerical technique for solving electromagnetic wave propagation and scattering problems 15, 16 . The AMF source was modeled based on coil schematics and magnetic core material properties (Fluxtrol Inc., Aubrun Hills, MI, USA). Boundaries are defined within the model which designate interfaces between materials of differing electrical permittivity, magnetic permeability, and electrical conductivity. The surfaces are assigned colocation points on the interface, for which an inner and outer point are assigned constituting a pair. These points define an inner and outer fictitious surface for each object. Each of these points pairs is designated as a magnetic dipole with unknown magnitude and direction, defined as being tangential to the surface, constituting four unknowns. These auxiliary sources are solved for directly using four boundary condition equations for each per pair (Eq. 1,2), resulting in a finite linear combination of analytical solutions to Maxwell's Equations.
These boundary conditions simply state that the tangential components of the electric and magnetic fields must be continuous between regions. β denotes regions of different electrical properties, is the unit normal vector of the surface between regions. The region of interest is then discretized and the field at every point is calculated directly from the contribution of all auxiliary sources of the fictitious surfaces outside the region of interest. This is accomplished using the Green's Function. Once the field has been solved within the region of interest, the induced current density can be calculated simply as the E field multiplied by the conductivity. The specific absorption rate (SAR, W/g) due to eddy currents is then calculated using Eq. 3,
where σ is the electrical conductivity (S/m) and is the current density (A/m 2 ). The model of magnetic nanoparticle heating will be discussed in an future publication, but for the purposes of the treatment planning model, it amounts to a second contribution to total SAR (Eq. 4).
= +
The total SAR distribution and thermal boundary conditions are then fed into a finite difference time domain (FDTD) heat transfer model, based on the Pennes Bioheat Equation (Eq. 5).
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Where ρ is the tissue density, kg/m 3 ; c is the specific heat of tissue, J/(kg °C); k is the thermal conductivity of tissue, W/(m °C); w b is the blood perfusion, ml/(m 3 ·s); ρ b is the density of blood, kg/m 3 ; c b is the specific heat of blood, J/(kg °C); T b temperature of blood, °C; and Q m is the metabolic heat generation rate, W/m 3 .
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AMF system characterization
One of the AMF coils used in these experiments is a single turn, pancake type coil with a magnetic core. It is powered by a 25kW generator (Fluxtrol Inc., Aubrun Hills, MI, USA), which drives 156 kHz AC current through the coil, thus generating a 156 kHz AMF. The magnetic field distribution produced by the pancake coil ( Fig. 1a) at 70% nominal power, was measured in 100 locations ( Fig. 1b ) and interpolated to produce the field map illustrated in Figure 1c .
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CONCLUSIONS
In this paper we developed and partially validated a coupled electromagnetic and thermal model of magnetic nanoparticle hyperthermia treatments. We were able to show good agreement between simulated and experimental eddy current distributions in homogeneous tissue mimicking phantom. Because the phantom experiments lack tissue perfusion, complex geometry, and inhomogeneous tissue electrical and thermal properties, the next logical step was to validate the model in an in vivo setting. Comparisons with previously attained murine flank tumor treatments in a solenoidal coil were made and shown to be in good agreement with the model, even when using simplified geometries, thermal boundary condition, and material property assumptions. Finally, a mouse with a flank tumor was treated on an open coil design to allow for thermal imaging and the ability to treat large volumes of tissue in the future. The preliminary data show that we are able to acquire meaningful surface temperature distributions during treatment which correlate well with internal temperature measurements and the computational results. Future work will include the addition of more mice to the thermal camera imaging treatment study, collection of histological biodistribution information, and evaluation of the ability of the model to predict temperature distribution given a priori particle distribution information of limited accuracy and spatial resolution. 
